| Canadian film auteur Cronenberg to pen first novel
Filmmaker David Cronenberg is moving from the silver screen to the written word, after netting a book deal with publisher Penguin Canada. The 64-year-old Toronto director is tentatively set to publish his novel — which will partially be set in his hometown — in February 2010. David Cronenberg, seen here at the 60th Cannes film festival in May, has signed a deal to pen his first novel. (Francois Mori/Associated Press) "I've literally been waiting 50 years to do this. I'm excited," Cronenberg said in a statement. The financial terms of the deal were not announced, nor were any details about the plot or the title of the book. In the past couple years, Cronenberg has won praise for his latest two features, the crime thrillers Eastern Promises and A History of Violence.
The Third-Most Odds-Defying Discovery in Targ's "Prayer and Healing ...
Targ originally chose to study AIDS because it was a "gnarly disease," medical science's greatest riddle.
During the AIDS pilot study, one of the patients developed brain cancer. Amazingly, this patient did not die and eventually made a full recovery. As it turned out, he had been in the treatment group - he had been prayed for. Fred Sicher, Targ's coauthor, reminded her of this patient after a confirmation study was completed. Although AIDS was no longer a death sentence, brain cancer still was. Could a healer 1,500 miles away really shrink a brain tumor? Targ learned all she could about a type of brain cancer called glioblastoma multiforme. In 2000, she applied to the National Institutes of Health's Center for Complementary and Alternative Medicine for $1.5 million to cover two 150-patient trials - one on brain cancer, and another confirmation study on AIDS.
Similarities In Dog And Human Breast Cancer Pre-malignant Lesions ...
ScienceDaily (Nov. 16, 2007) Pre-malignant mammary lesions in dogs and humans display many of the same characteristics, a discovery that could lead to better understanding of breast cancer progression and prevention for people and pets, said a Purdue University scientist from the School of Veterinary Medicine. .
UN Country Code: 662
This is a multidimensional query tool that offers a collection of 108 indicators from 1995 to 2005. The system presents data and indicators on:
- demography
- socioeconomic
- mortality by cause indicators
- morbidity and risk factors
- access, resources and health services coverage.
Selected indicators are disaggregated into age groups, sex and/or urban/rural region. Generated tables can be exported and printed.
The data presented is updated annually with the latest country information.
------------------------------ HEALTH SITUATION ANALYSIS AND TRENDS SUMMARY
GENERAL SITUATION AND TRENDS| SPECIFIC HEALTH PROBLEMS | RESPONSE OF THE HEALTH SYSTEM GENERAL SITUATION AND TRENDS
St.
Some with breast cancer can skip chemo
Thousands of breast cancer patients each year could be spared chemotherapy or get gentler versions of it without harming their odds of beating the disease, new research suggests. One study found that certain women did better - were less likely to die or have a relapse - if given a less harsh drug than Adriamycin, a mainstay of treatment for decades. Another study found that a gene test can help predict whether some women need chemo at all - even among those whose cancer has spread to their lymph nodes, which typically brings full treatment now. The findings are sure to speed the growing trend away from chemo for many breast cancer patients and targeting it to a smaller group of women who truly need it, doctors said Thursday at the San Antonio Breast Cancer Symposium, where the studies were reported.
Non-Caucasians at higher risk for severe metastatic breast cancer pain
A new study finds significant racial differences in the risk of pain related to metastatic breast cancer. An analysis by Dr. Liana Castel of the University of North Carolina at Chapel Hill and colleagues found that non-whites experience poorer pain control among women with this disease. The study is published in the January 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society. Studies indicate that chronic or recurrent pain affects 30 percent of all cancer patients and 60 to 90 percent of patients with advanced cancer. Age, race, tumor type, genetics, psychosocial context, and culture can all affect pain. However, it is unclear how pain is influenced by changes over the course of disease due to factors including radiation, surgery, and chemotherapy.
MicroRNA regulates cancer stem cells
Now, researchers have devised a way to generate large numbers of human breast cancer stem cells in mice and have discovered a genetic switch that regulates critical properties of the cells. The regulator, which belongs to a class of molecules called microRNAs (microRNAs), pushes the stem cells to become more differentiated and less tumorigenic through its ability to switch off particular genes.
�People know that microRNAs are important regulators of cell differentiation, but nobody has shown that they regulate the critical properties of cancer stem cells, or any kind of stem cells,� says Judy Lieberman, an investigator at the Immune Disease Institute and Harvard Medical School professor of pediatrics at Children�s Hospital Boston. Lieberman and Erwei Song, a former postdoc in her lab now working as a breast cancer surgeon at Sun Yat-Sen University in Guangzhou, China, are the senior investigators on the work, which appears in the Dec.
|
